Breast Cancer Trial Talk

Dil
  • 5.0 (1)
  • Education
  • Updated Semiweekly

Breast Cancer Trial Talk explains breast cancer clinical trials in clear, simple language. Each episode breaks down trial design, eligibility, treatments, endpoints, results, and patient questions, helping patients, families, students, and advocates understand the science behind new breast cancer therapies. Educational only, not medical advice.

Episodes

  1. Jun 17

    GLP-1 Weight-Loss Drugs and Breast Cancer: What Are Researchers Studying?

    In this episode of Breast Cancer Trial Talk, we explore what researchers are studying about GLP-1 weight-loss drugs and breast cancer. We focus on tirzepatide trials in early-stage hormone receptor-positive, HER2-negative breast cancer, including studies looking at weight loss, ctDNA, recurrence risk, and breast cancer prevention biomarkers. We also discuss what current research suggests about GLP-1 receptor agonists and breast cancer risk, survival, and recurrence — and why the evidence is still early. These medications are not breast cancer treatments, and we are still waiting for results from prospective clinical trials. Educational only — not medical advice. Please talk with your oncologist or healthcare team before making treatment decisions. Sources used in this episode: NCI Trial: Tirzepatide and Weight Loss in HR+/HER2− Breast Cancerhttps://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2024-09187 ClinicalTrials.gov: NCT06517212 / TRIM-EBChttps://clinicaltrials.gov/study/NCT06517212 NCI Trial: Tirzepatide and Breast Cancer Risk Biomarkershttps://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2024-08187 JAMA Network Open: Survival and Recurrence With GLP-1 Receptor Agonists in Breast Cancerhttps://jamanetwork.com/journals/jamanetworkopen/fullarticle/2848788 Journal of Clinical Investigation: GLP-1 Receptor Agonists and Cancerhttps://www.jci.org/articles/view/194743 JAMA Oncology: GLP-1 Receptor Agonists and Cancer Risk in Adults With Obesityhttps://jamanetwork.com/journals/jamaoncology/fullarticle/2837999 Journal of Clinical Endocrinology & Metabolism: Do GLP-1 Receptor Agonists Increase the Risk of Breast Cancer?https://academic.oup.com/jcem/article/106/3/912/6009065

    GLP-1 Weight-Loss Drugs and Breast Cancer: What Are Researchers Studying?

  2. Jun 15

    What Is a Clinical Trial? Phase 1, 2, and 3 Explained Simply

    In this first episode of Breast Cancer Trial Talk, we explain what a clinical trial is and why clinical trials matter in cancer care. We break down Phase 1, Phase 2, and Phase 3 trials in simple language, including safety, dosing, effectiveness, standard treatment, eligibility criteria, randomization, and informed consent. This episode is made for patients, families, students, and anyone who wants to better understand how new cancer treatments are tested before they become widely available. Educational only — not medical advice. Please talk with your oncologist or healthcare team before making treatment decisions. Sources used in this episode: NCI — How Do Clinical Trials Work? https://www.cancer.gov/research/participate/clinical-trials/how-trials-work NIH — The Basics of Clinical Trials https://www.nih.gov/health-information/nih-clinical-research-trials-you/basics FDA — Step 3: Clinical Research https://www.fda.gov/patients/drug-development-process/step-3-clinical-research American Cancer Society — Phases of Clinical Trials https://www.cancer.org/cancer/managing-cancer/making-treatment-decisions/clinical-trials/phases-of-clinical-trials.html NCI — Understanding Informed Consent https://www.cancer.gov/research/participate/plan/informed-consent

    What Is a Clinical Trial? Phase 1, 2, and 3 Explained Simply
  • 2 Episodes

About

Breast Cancer Trial Talk explains breast cancer clinical trials in clear, simple language. Each episode breaks down trial design, eligibility, treatments, endpoints, results, and patient questions, helping patients, families, students, and advocates understand the science behind new breast cancer therapies. Educational only, not medical advice.

Information